跳至主要内容
临床试验/NCT00597662
NCT00597662已完成1 期

Safety Study of Polylactide-Caprolactone-Trimethylenecarbonate Copolymer for Post-Operative Adhesion Prophylaxis

University Hospital Tuebingen2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2008年1月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
30
试验地点
2
主要终点
Difference in visual analogue pain score on visit 8 after discharge minus visit 1 on admission

研究概览

简要总结

The purpose of this study is to compare adhesion prophylaxis with polylactide-caprolactone-trimethylenecarbonate copolymer to icodextrin 4% in terms of safety, side effects and usability in addition to gaining early evidence of the effectiveness of polylactide-caprolactone-trimethylenecarbonate copolymer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • age 18-60 years
  • sex female
  • laparoscopic myomectomy indicated
  • ability and intention to conform to the study protocol
  • written informed consent

排除标准

  • pregnancy
  • indication for laparotomy
  • inflammatory bowel disease
  • additional surgical interventions
  • known or suspected intollerance or hypersensibility to the interventions
  • chronic pain
  • systemic corticoids or irradiation
  • alcohol abuse or other substance abuse
  • clinical signs of malignancy
  • psychiatric or neurological disease
  • participation in another clinical trial within 30 days
  • inability to understand the purpose of the trial or to conform to the study protocol
  • absence of written informed consent
  • inflammation of pelvic organs
  • presence of adhesions which lead to a conversion from laparoscopy to laparotomy
  • concurrent therapy with corticoids, anti-neoplastic agents or irradiation
  • maintenance therapy with non-steroidal anti-inflammatory drugs or analgesics

结局指标

主要结局

Difference in visual analogue pain score on visit 8 after discharge minus visit 1 on admission

时间窗: 3 months

次要结局

  • Dysmenorrhoea(3 months)
  • Dyspareunia(3 months)
  • Constipation(3 months)
  • Diarrhoea(3 months)
  • Nausea(3 months)
  • Duration of adhesion prophylaxis(Day 1)
  • Post-operative infection(3 months)
  • Requirement for re-operation(3 months)
  • Post-operative pyrexia(3 months)
  • Use of analgesia(1, 2 and 3 days)
  • Usability as assessed by surgeon(Day 1)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验